Teligent Price to Book Ratio 2010-2021 | TLGT

Historical price to book ratio values for Teligent (TLGT) over the last 10 years. The current price to book ratio for Teligent as of November 20, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Teligent Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-15 0.17 0.00
2021-06-30 0.53 $-0.47 -1.14
2021-03-31 0.62 $-0.36 -1.72
2020-12-31 0.75 $-5.06 -0.15
2020-09-30 0.72 $-6.27 -0.11
2020-06-30 2.42 $-7.01 -0.35
2020-03-31 2.80 $-5.91 -0.47
2019-12-31 4.26 $-0.99 -4.32
2019-09-30 9.50 $-0.03 -329.79
2019-06-30 6.30 $1.24 5.06
2019-03-31 11.60 $1.90 6.11
2018-12-31 13.70 $3.43 4.00
2018-09-30 39.50 $6.64 5.95
2018-06-30 34.60 $7.23 4.78
2018-03-31 33.60 $7.53 4.46
2017-12-31 36.30 $8.38 4.33
2017-09-30 67.10 $9.46 7.09
2017-06-30 91.50 $10.94 8.36
2017-03-31 78.10 $10.95 7.13
2016-12-31 66.10 $10.66 6.20
2016-09-30 76.00 $11.62 6.54
2016-06-30 71.40 $12.01 5.94
2016-03-31 49.00 $12.54 3.91
2015-12-31 89.00 $12.60 7.07
2015-09-30 65.40 $13.72 4.77
2015-06-30 63.00 $14.11 4.46
2015-03-31 81.60 $8.78 9.29
2014-12-31 88.00 $7.41 11.88
2014-09-30 93.20 $6.26 14.90
2014-06-30 53.10 $1.69 31.35
2014-03-31 56.50 $1.69 33.45
2013-12-31 30.50 $1.54 19.83
2013-09-30 18.20 $1.41 12.93
2013-06-30 14.30 $1.43 9.99
2013-03-31 17.10 $1.49 11.49
2012-12-31 10.40 $1.51 6.91
2012-09-30 12.40 $1.27 9.76
2012-06-30 10.30 $1.60 6.45
2012-03-31 10.90 $1.72 6.35
2011-12-31 11.50 $1.87 6.14
2011-09-30 11.00 $1.98 5.55
2011-06-30 11.10 $2.08 5.34
2011-03-31 15.30 $2.28 6.72
2010-12-31 16.80 $2.51 6.70
2010-09-30 15.10 $1.32 11.48
2010-06-30 10.10 $2.79 3.62
2010-03-31 7.10 $3.25 2.19
2009-12-31 7.80 $2.76 2.83
2009-09-30 10.40 $3.58 2.90
2009-06-30 11.50 $4.26 2.70
2009-03-31 6.90 $2.41 2.86
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00